Skip to main content

Alnylam: Q1 Earnings Snapshot

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Alnylam Pharmaceuticals Inc. (ALNY) on Thursday reported first-quarter net income of $206 million, after reporting a loss in the same period a year earlier.

The Cambridge, Massachusetts-based company said it had profit of $1.51 per share. Earnings, adjusted for stock option expense, were $1.99 per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.43 per share.

The RNA interference drug developer posted revenue of $1.17 billion in the period, which also beat Street forecasts. Eight analysts surveyed by Zacks expected $1.13 billion.

Alnylam shares have declined 24% since the beginning of the year. The stock has risen 17% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALNY at https://www.zacks.com/ap/ALNY

One Tech Tip: What to know about flying with lithium ion portable battery chargers

Jetting off soon for summer travels? If you're planning on bringing an extra battery charger for your phone or other devices, be aware of the latest rules when taking one on a flight. Rechargeable lithium-ion portable battery chargers, also known as power banks, come in protective enclosures of various shapes and sizes. They're a handy and popular way for getting more juice when you're on the move. But after a spate of smoke or fire incidents, U.S. and international aviation authorities have issued new guidelines and airlines have tightened up rules for passengers. Here's a guide on flying with power banks.
Read Next Story

Related News

Knicks take 1-0 lead into game 2 against the Spurs

Beijing bans 4 New Zealand lawmakers from entering China because they visited Taiwan

Police warn families of Tiananmen crackdown dead not to visit graves on 37th anniversary